Lisa M. Massoudi

Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models

Andrés Obregón‐Henao, Kimberly Arnett, Marcela Henao‐Tamayo et al. · Antimicrobial Agents and Chemotherapy · 2015 · 119 citations · Full text

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832

Gregory T. Robertson, Michelle E. Ramey, Lisa M. Massoudi et al. · Antimicrobial Agents and Chemotherapy · 2021 · 76 citations · Full text

Tuberculosis Treatment, Drug Target, Dpre1 Inhibitors Tba-7371 +19

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth

Peter C. Ray, Margaret Huggett, Penelope A. Turner et al. · ACS Omega · 2021 · 33 citations · Full text

Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

Caroline Wilson, Peter C. Ray, Fabio Zuccotto et al. · Journal of Medicinal Chemistry · 2021 · 33 citations · Full text

Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responses

Nicholas D. Walter, Jacqueline P. Ernest, Christian Dide-Agossou et al. · Antimicrobial Agents and Chemotherapy · 2023 · 28 citations · Full text